This website uses cookies to improve your experience. You can accept or reject analytics cookies
Plan Nacional De Preparación Para Una Pandemia De Influenza
Pandemic Preparedness and ResponseNational Control Plan2007
ChileSpanishPDF
National
AI-Generated Document Summary
Objectives
Chile’s national influenza-pandemic preparedness plan provides a flexible framework, aligned with World Health Organization guidance, to reduce mortality, morbidity, social disruption and economic impact from a novel, readily transmissible influenza subtype.It covers the interpandemic, pandemic-alert, pandemic and post-pandemic periods, with actions and responsible bodies structured around evolving epidemiological conditions.
Strengthen preparedness at global, regional, national and local levels during the earliest phase of risk.
Minimise animal-to-human transmission through coordinated human and animal surveillance, prevention and control.
Ensure early detection, notification, laboratory confirmation and response to suspected or confirmed cases.
Contain limited foci and delay wider spread during phases of confirmed or increasing person-to-person transmission.
Minimise pandemic impact through coordinated emergency management, health-service continuity, infection prevention and control, surveillance, vaccines, antivirals, public-health measures and communications.
Assess the first pandemic wave and subsequent impact, identify lessons learned, and update preparedness arrangements for future events.
The plan’s principal operational areas are epidemiological and laboratory surveillance; community control and risk communication; healthcare-network response and infection control; disease-specific measures, including vaccination and antivirals; and animal surveillance and control.Its phase objectives progress from maintaining preparedness in Phase 1, reducing zoonotic risk in Phase 2 and detecting cases early in Phase 3, to containing or delaying spread in Phases 4 and 5 and mitigating sustained population transmission in Phase 6.
Implementation
Implementation combines national leadership, regional coordination, intersectoral participation and phase-specific operational measures. The Ministry of Health coordinates preparedness through the National Commission for Response to Outbreaks and Health Emergencies, supported by political, technical and executive structures, while emergency arrangements intensify as transmission escalates.During sustained pandemic transmission, coordination shifts to an Emergency Committee, with national and regional plans activated according to the epidemic’s evolution.
Coordinate government and societal participation through bodies involving the Ministry of Health, Ministry of the Interior, Ministry of Labour and Social Welfare, Ministry of Education, Ministry of Finance, Ministry of Defence, National Emergency Office, Armed Forces and police, municipalities, private clinics, scientific societies and other public- and private-sector actors.
Maintain national and regional governance arrangements, including regional commissions under Regional Health Authorities, emergency committees, technical working groups and reporting links to the national commission.
Conduct routine and intensified surveillance, investigate outbreaks and suspected cases, notify health authorities and international organisations, submit samples for viral identification and characterisation, and coordinate human and animal-health surveillance with the Agricultural and Livestock Service.
Strengthen laboratory capacity through the Public Health Institute, including viral isolation, antigenic typing, biosafety arrangements, access to reagents and coordination with university and private laboratories.
Prepare the health system through referral protocols, hospital-bed conversion, patient-flow reorganisation, staff recruitment or redistribution, staff rotas, infection-control measures, personal protective equipment, respiratory support equipment and supply management.
Apply phased community measures, including traveller advice and controls, contact tracing and monitoring, hygiene promotion, school-closure or gathering-restriction measures, voluntary or compulsory confinement for symptomatic people where considered necessary, and telephone advice lines or fever clinics during localised outbreaks.
Communicate risks through designated national and regional spokespersons, regular press briefings, media collaboration, public information and an updated pandemic website.
Use seasonal vaccination, review priority groups, maintain antiviral stocks, arrange pandemic-vaccine procurement, distribute medicines and supplies, and use vaccination according to vaccine availability and prioritisation.
Monitoring relies on progressively intensified notification, surveillance and situation reporting. During pandemic phases, the plan provides for daily monitoring of respiratory consultations, bed use and availability, deaths, respiratory morbidity and mortality, as well as national and international situation reports.It requires all positive influenza A samples to be sent to the Public Health Institute for isolation and typing in the specified phase, while later surveillance prioritises samples from sentinel centres and hospitalised patients.Post-wave evaluation covers morbidity, mortality, economic impact, resource use and the effectiveness of control measures, producing lessons and recommendations to update the plan.
Resource mobilisation includes budgetary and logistical support, procurement and territorial distribution of medicines, equipment and supplies through the Central Supply Office, extraordinary response resources prioritised by the Emergency Committee, and replenishment after the first wave.The supplied material does not specify a total monetary budget, funding sources, allocations, quantified funding gaps or a formal independent accountability mechanism.
Monitoring & Evaluation
Monitoring and accountability are organised around progressively intensified epidemiological, laboratory, animal-health and health-service surveillance across the alert, pandemic and post-pandemic periods. The framework links objectives to World Health Organization phases, from preparedness and early detection through containment, mitigation and post-pandemic review.
Maintain routine human and animal influenza surveillance during the interpandemic period, reinforce sentinel-centre coverage for morbidity and circulating viruses, investigate outbreaks, and conduct passive and active surveillance for avian influenza in poultry establishments.
Notify suspected cases and submit samples for virus identification, isolation, antibody research and antigenic typing through the national public-health laboratory system.
Intensify investigation and follow-up of cases, clusters, travellers, contacts, exposed poultry workers and their families as transmission risk increases.
Monitor World Health Organization information, disseminate alerts to health authorities and surveillance networks, strengthen notification and case definitions, and expand surveillance of pneumonia, severe respiratory disease and illness among health workers.
Use pandemic-plan exercises during Phase 2 to assess implementation and make corrections, and reassess preparedness arrangements as the epidemiological scenario evolves.
Assign animal surveillance to the Agricultural and Livestock Service, including emergency action under its contingency plans where a strain is of animal origin, while coordinating closely with the Ministry of Health.
Provide periodic information to the population, public authorities and international organisations through reports, designated spokespersons, daily press briefings and an updated pandemic website.
Produce national and international situation reports during the pandemic, with daily reporting of respiratory morbidity and mortality, geographical spread, epidemiological and clinical changes in the virus, and severe acute respiratory infection clusters of unknown cause.
Send all positive influenza A samples to the Public Health Institute for isolation and typing during the specified pandemic phase, coordinate public, university and private laboratories, and monitor antiviral resistance.
Report daily during Phases 5 and 6 on respiratory consultations, emergency attendances, adult and paediatric bed use and availability, and deaths.
Evaluate the effectiveness of antiviral and public-health measures after the pandemic wave begins, and assess the first wave's morbidity, mortality, economic impact and resource use.
Review post-pandemic impact, identify lessons learned, prepare reports and recommendations for publication, update the plan, and restore enhanced surveillance in preparation for subsequent waves.
Operational accountability rests with national and regional emergency committees, Regional Health Authorities, health-service directorates and surveillance networks.The supplied material does not specify a comprehensive quantitative indicator framework, standard reporting templates, independent audit arrangements or accountability sanctions.
Costing & Financing
Financing provisions focus on securing and administering resources for pandemic control, logistics, medicines, vaccines, diagnostic capacity and health-service surge requirements. No numerical budget, currency-denominated allocation, financing source, quantified funding gap, costing methodology or economic assumption is provided in the supplied material.
Assign budgetary support to secure resources required for pandemic-control activities and logistical support to procure and distribute medicines and supplies nationally through the Central Supply Office.
Maintain antiviral stocks, reassess their availability and condition, arrange contracts or alternative mechanisms for pandemic-vaccine acquisition, and initiate procurement when required during alert phases.
Distribute response resources to regions and healthcare establishments during Phase 4, without specifying the amount or budget source.
Provide extraordinary resources during the pandemic response, administered according to priorities established by the Emergency Committee.
Plan for additional staffing and procure respiratory-support equipment, ventilators, rapid diagnostic kits, personal protective equipment, disinfectants, medicines and other operational supplies.
Acquire pandemic-strain vaccine where available, distribute antivirals and vaccines according to priority groups and supply, and replenish medicines and supplies after the first pandemic wave.
Although reducing economic impact is a strategic objective and post-wave evaluation includes economic impact and resource use, the material does not provide economic forecasts, cost-effectiveness assumptions or funding-gap estimates.